Meeting
2018 ASCO Annual Meeting
Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant.
Authors
Yasser Ged
Memorial Sloan Kettering Cancer Center, New York, NY
Yasser Ged , Andrea Knezevic , Yingbei Chen , Almedina Redzematovic , Maria Isabel Carlo , Chung-Han Lee , Darren R. Feldman , Sujata Patil , Robert J. Motzer , Martin Henner Voss
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 4577)
DOI
10.1200/JCO.2018.36.15_suppl.4577
Abstract #
4577
Poster Bd #
403
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF).
First Author: Yasser Ged
Poster
2015 Genitourinary Cancers Symposium
Identification of actionable targets in chromophobe renal cell carcinoma detected by multiplatform molecular analysis.
First Author: Philip Abbosh
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Comprehensive molecular profiling in patients with advanced biliary tract cancers (BTC) in a Latinx-rich cohort.
First Author: Vidit Kapoor
Poster
2022 ASCO Annual Meeting
Molecular alterations associated with rapid progression following CDK4/6 inhibitors (CDKi) in metastatic hormone receptor–positive breast cancer (mHRBC).
First Author: Malinda T West